Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions

Psychiatry and Clinical Neurosciences

Volumn 64, Issue 4, 2010, Pages 341-357

  Hashimoto, Kenji ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

biomarker; brain derived neurotrophic factor; gene; mood disorders; post mortem brain

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; LAMOTRIGINE; LITHIUM; PROTEIN PRECURSOR; VALPROIC ACID; BRAIN-DERIVED NEUROTROPHIC FACTOR PRECURSOR;

BIPOLAR DISORDER; CADAVER; DEPRESSION; DISEASE SEVERITY; DRUG MECHANISM; ELECTROCONVULSIVE THERAPY; GENETIC ANALYSIS; HUMAN; KNOCKOUT MOUSE; MAJOR DEPRESSION; MENTAL DISEASE; MOOD DISORDER; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; TRANSCRANIAL MAGNETIC STIMULATION; ANIMAL; BLOOD; DEPRESSIVE DISORDER, MAJOR; GENETIC POLYMORPHISM; GENETICS; MOOD DISORDERS; MOUSE; PHYSIOLOGY;

ANIMALS; BIOLOGICAL MARKERS; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; HUMANS; MICE; MOOD DISORDERS; POLYMORPHISM, GENETIC; PROTEIN PRECURSORS;

EID: 77955078119     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2010.02113.x     Document Type: Review

References (176)

1. Kessler RC, McGonagle KA, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 1994 51 : 8 19.
2. Hirschfeld RM, Weissman MM. Risk factors for major depression and bipolar disorder. In : Davis KL, Charney D, Coyle JT, Nemeroff C (eds). Neuropsychopharmacology - The Fifth Generation of Progress. Lippincott Williams & Wilkins
3. Belmaker RH, Agam G. Major depressive disorder. N. Eng. J. Med. 2008 358 : 55 68.
4. Costello EJ, Pine DS, Hammen C et al. Development and natural history of mood disorders. Biol. Psychiatry 2002 52 : 529 542.
5. Merikangas KR, Chakravarti A, Moldin SO et al. Future of genetics of mood disorders research. Biol. Psychiatry 2002 52 : 457 577.
6. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron 2002 34 : 13 25.
7. Nestler EJ, Gould E, Manji HK et al. Preclinical models: Status of basic research in depression. Biol. Psychiatry 2002 52 : 503 528.
8. Spearing M. Bipolar Disorder. NIH Publication
9. Belmaker RH. Bipolar disorder. N. Eng. J. Med. 2004 351 : 476 486.
10. Taylor E. Managing bipolar disorders in children and adolescents. Nat. Rev. Neurol. 2009 5 : 484 491.
11. Ising M, Horsmann S, Kloiber S et al. Combined dexamethasone/ corticotrophin releasing hormone test predicts treatment response in major depression - a potential biomarker. Biol. Psychiatry 2007 62 : 47 54.
12. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009 65 : 732 741.
13. Lakhan SE, Vieira K, Hamlat E. Biomarkers in psychiatry: Drawbacks and potential for misuse. Int. Arch. Med. 2010 3 : 1.
14. Domenici E, Wille DR, Tozzi F et al. Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS ONE 2010 5 : e9166.
15. Huang EJ, Reichardt LF. Neurotrophins: Roles in neuronal development and function. Annu. Rev. Neurosci. 2001 24 : 677 736.
16. Schinder AF, Poo M. The neurotrophin hypothesis for synaptic plasticity. Trends Neurosci. 2000 23 : 639 645.
17. Lu B, Pang PT, Woo NH. The Yin and Yang of neurotrophin action. Nat. Rev. Neurosci. 2005 6 : 603 614.
18. Chao MV, Rajagopal R, Lee FS. Neurotrophin signaling in health and disease. Clin. Sci. (Lond). 2006 110 : 167 173.
19. Reichardt LF. Neurotrophin-regulated signaling pathways. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2006 361 : 1545 1564.
20. Malcangio M, Lessmann V. A common thread for pain and memory synapses? Brain-derived neurotrophic factor and trkB receptors. Trends Pharmacol. Sci. 2003 24 : 116 121.
21. Lu Y, Christian K, Lu B. BDNF: A key regulator for protein synthesis dependent LTP and long term memory. Neurobiol. Learn. Mem. 2008 89 : 312 323.
22. Seidah NG, Benjannet S, Pareek S, Chrétien M, Murphy RA. Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases. FEBS Lett. 1996 379 : 247 250.
23. Mowla SJ, Pareek S, Farhardi HF et al. Differential sorting of nerve growth factor and brain-derived neurotrophic factor in hippocampal neurons. J. Neurosci. 1999 19 : 2069 2080.
24. Mowla SJ, Farhadi HF, Pareek S et al. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J. Biol. Chem. 2001 276 : 12660 12666.
25. Greenberg ME, Xu B, Lu B, Hempstead BL. New insights in the biology of BDNF synthesis and release: Implications in CNS function. J. Neurosci. 2009 29 : 12764 12767.
26. Lee R, Kermani P, Teng KK, Hempstead BL. Regulation of cell survival by secreted proneurotrophins. Science 2001 294 : 1945 1948.
27. Pang PT, Teng HK, Zaitsev E et al. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 2004 306 : 487 491.
28. NTR by proBDNF facilitates hippocampal long-term depression. Nat. Neurosci. 2005 8 : 1069 1077.
29. NTR and sortilin. J. Neurosci. 2005 25 : 5455 5463.
30. Lu B. Pro-region of neurotrophins: Role in synaptic modulation. Neuron 2003 39 : 735 738.
31. Hashimoto K. BDNF variant linked to anxiety-related behaviors. Bioessays 2007 29 : 116 119.
32. Barker PA. Whither proBDNF? Nat. Neurosci. 2009 12 : 105 106.
33. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav. 1997 56 : 131 137.
34. Russo-Neustadt A, Ha T, Ramirez R, Kesslak JP. Physical activity-antidepressant treatment combinations: Impact on brain-derived neurotrophic factor and behavior in an animal model. Behav. Brain Res. 2001 120 : 87 95.
35. Shirayama Y, Chen ACH, Nakagawa S, Russell DS, Duman RS. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 2002 22 : 3251 3261.
36. Eisch AJ, Bolanos CA, de Wit J et al. Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: A role in depression. Biol. Psychiatry 2003 54 : 994 1005.
37. Ernfors P, Lee KF, Jaenisch R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 1994 368 : 147 150.
38. Jones KR, Farinas I, Backus C, Reichardt LF. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 1994 76 : 989 999.
39. Altar CA, Whitehead RE, Chen R, Wörtwein G, Madsen TM. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol. Psychiatry 2003 54 : 703 709.
40. Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. U.S.A. 1995 92 : 8856 8860.
41. Kolbeck R, Bartke I, Eberle W, Barde YA. Brain-derived neurotrophic factor levels in the nervous system of wild-type and neurotrophin gene mutant mice. J. Neurochem. 1999 72 : 1930 1938.
42. Lyons WE, Mamounas LA, Ricaurte GA et al. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc. Natl. Acad. Sci. U.S.A. 1999 96 : 15239 15244.
43. Koizumi H, Hashimoto K, Iyo M. Dietary restriction changes behaviors in brain-derived neurotrophic factor heterozygous mice: Role of serotonergic system. Eur. J. Neurosci. 2006 24 : 2335 2344.
44. Kernie SG, Liebl DJ, Parada LF. BDNF regulates eating behavior and locomotor activity in mice. EMBO J. 2000 19 : 1290 1300.
45. Rios M, Fan G, Fekete C et al. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol. Endocrinol. 2001 15 : 1748 1757.
46. MacQueen GM, Ramakrishnan K, Croll SD et al. Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav. Neurosci. 2001 115 : 1145 1153.
47. Saarelainen T, Hendolin P, Lucas G et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J. Neurosci. 2003 23 : 349 357.
48. Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: Recent developments and future needs. Trends Pharmacol. Sci. 2002 23 : 238 245.
49. Monteggia LM, Luikart B, Barrot M et al. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol. Psychiatry 2007 61 : 187 197.
50. Adachi M, Barrot M, Autry AE, Theobald D, Monteggia LM. Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol. Psychiatry 2008 63 : 642 649.
51. Chen ZY, Jing D, Bath KG et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science. 2006 314 : 140 143.
52. Duman RS, Henninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 1997 54 : 597 606.
53. Altar CA. Neurotrophins and depression. Trends Pharmacol. Sci. 1999 20 : 59 61.
54. Coyle JT, Duman RS. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 2003 38 : 157 160.
55. Hashimoto K, Shimizu E, Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res. Brain Res. Rev. 2004 45 : 104 114.
56. Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat. Neurosci. 2007 10 : 1089 1093.
57. Deltheil T, Guiard BP, Cerdan J et al. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology 2008 55 : 1006 1014.
58. Hashimoto K. Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res. Brain Res. Rev. 2009 61 : 105 123.
59. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 1995 15 : 7539 7547.
60. Nibuya M, Morinobu S, Duman RS. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 1996 16 : 2365 2372.
61. Russo-Neustadt A, Beard RC, Cotman CW. Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 1999 21 : 679 682.
62. Nibuya M, Takahashi M, Russell DS, Duman RS. Repeated stress increases catalytic TrkB mRNA in rat hippocampus. Neurosci. Lett. 1999 267 : 81 84.
63. Smith MA, Makino S, Kim SY, Kvetnansky R. Stress increases brain-derived neurotropic factor messenger ribonucleic acid in the hypothalamus and pituitary. Endocrinology 1995 136 : 3743 3750.
64. Smith MA, Makino S, Kvetnansky R, Post RM. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci. 1995 15 : 1768 1777.
65. Tamminga CA, Nemeroff CB, Blakely RD et al. Developing novel treatments for mood disorders: Accelerating discovery. Biol. Psychiatry 2002 52 : 589 609.
66. Lisanby SH. Electroconvulsive therapy for depression. N. Eng. J. Med. 2007 357 : 1939 1945.
67. Lindeforts N, Brodin E, Metsis M. Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNA in rat hippocampus by electroconvulsive shock. Neuroscience 1995 65 : 661 670.
68. Angelucci F, Aloe L, Vasquez PJ, Mathe AA. Mapping the differences in the brain concentration of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression. NeuroReport 2000 11 : 1369 1373.
69. Vaidya VA, Siuciak JA, Du F, Duman RS. Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience 1999 89 : 157 166.
70. Gersner R, Toth E, Isserles M, Zangen A. Site-specific antidepressant effects of repeated subconvulsive electrical stimulation: Potential role of brain-derived neurotrophic factor. Biol. Psychiatry 2010 67 : 125 132.
71. Hoffman RE, Cavus I. Slow transcranial magnetic stimulation, long-term depotentiation, and brain hyperexcitability disorders. Am. J. Psychiatry 2002 159 : 1093 1102.
72. Gershon AA, Dannon PN, Grunhaus L. Transcranial magnetic stimulation in the treatment of depression. Am. J. Psychiatry 2003 160 : 835 845.
73. Schlaepfer TE, Kosel M, Nemeroff CB. Efficacy of repetitive transcranial magnetic stimulation (rTMS) in the treatment of affective disorders. Neuropsychopharmacology 2003 28 : 201 205.
74. Müller MB, Toschi N, Kresse AE, Post A, Keck ME. Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology 2000 23 : 205 215.
75. Lenox RH, Wang L. Molecular basis of lithium action: Integration of lithium-responsive signaling and gene expression networks. Mol. Psychiatry 2003 8 : 135 144.
76. Manji HK, Moore GJ, Chen G. Bipolar disorder: Leads from the molecular and cellular mechanisms of action of mood stabilizers. Br. J. Psychiatry 2001 41 : s107 s119.
77. Manji HK, Quiroz JA, Sporn J et al. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol. Psychiatry 2003 53 : 707 742.
78. Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology 2001 158 : 100 106.
79. Hashimoto R, Takei N, Shimazu K, Christ L, Lu B, Chuang DM. Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: An essential step for neuroprotection against glutamate excitotoxicity. Neuropharmacology 2002 43 : 1173 1179.
80. Li N, He X, Qi X, Zhang Y, He S. The mood stabilizer lamotrigine produces antidepressant behavioral effects in rats: Role of brain-derived neurotrophic factor. J. Psychopharmacol. 2010. doi:10.1177/0269881109359102
81. Chuang DM. Neuroprotective and neurotrophic actions of the mood stabilizer lithium: Can it be used to treat neurodegenerative diseases? Crit. Rev. Neurobiol. 2004 16 : 83 90.
82. Maisonpierre PC, Le Beau MN, Espinosa R et al. Human and rat brain-derived neurotrophic factor and neurotrophin-3: Gene structures, distributions, and chromosomal localizations. Genomics 1991 10 : 558 568.
83. Egan MF, Kojima M, Callicott JH et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003 112 : 257 269.
84. Hariri AR, Goldberg TE, Mattay VS et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 2003 23 : 6690 6694.
85. Avissar S, Schreiber G. Toward molecular diagnostics of mood disorders in psychiatry. Trends Mol. Med. 2002 8 : 294 300.
86. Baron M. Manic-depression genes and the new millennium: Poised for discovery. Mol. Psychiatry 2002 7 : 342 358.
87. Sklar P. Linkage analysis in psychiatric disorders: The emerging picture. Annu. Rev. Genomics Hum. Genet. 2003 3 : 371 413.
88. Tsai SJ, Cheng CY, Yu YWY, Chen TJ, Hong CJ. Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am. J. Med. Genet. 2003 123B : 19 22.
89. Hong CJ, Huo SJ, Yen FC, Tung CL, Pan GM, Tsai SJ. Association study of a brain-derived neurotrophic factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 2003 48 : 186 189.
90. Iga J, Ueno S, Yamauchi K et al. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2007 144B : 10003 11006.
91. Sarchiapone M, Carli V, Roy A et al. Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients. Neuropsychobiology 2008 57 : 139 145.
92. Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with geriatric depression. Neurobiol. Aging 2006 27 : 1834 1837.
93. Borroni B, Archetti S, Costanzi C et al. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression. Neurobiol. Aging 2009 30 : 1406 1412.
94. Schumacher J, Jamra RA, Becker T et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry 2005 58 : 307 314.
95. Licinio J, Dong C, Wong ML. Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response. Arch. Gen. Psychiatry 2009 66 : 488 497.
96. Domschke K, Lawford B, Laje G et al. Brain-derived neurotrophic factor (BDNF) gene: No major impact on antidepressant treatment response. Int. J. Neuropsychopharmacol. 2010 13 : 93 101.
97. Zou YF, Ye DQ, Feng XL, Su H, Pan FM, Liao FF. Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder. Eur. Neuropsychopharmacol. 2010. doi:10.1016/j.euroneuro. 2009.12.005
98. Kohli MA, Salyakina D, Pfennig A et al. Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients. Arch. Gen. Psychiatry 2010 67 : 348 359.
99. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. U.S.A. 1996 93 : 3908 3913.
100. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. Am. J. Psychiatry 2000 157 : 115 118.
101. Campbell S, Marriott M, Nahmias C, MacQueen GM. Lower hippocampal volume in patients suffering from depression: A meta-analysis. Am. J. Psychiatry 2004 161 : 598 607.
102. Videbech P, Ravnkilde B. Hippocampal volume and depression: A meta-analysis of MRI studies. Am. J. Psychiatry 2004 161 : 1957 1966.
103. Koolschijn PC, van Haren NE, Lensvelt-Mulders GJ, Hulshoff Pol HE, Kahn RS. Brain volume abnormalities in major depressive disorder: A meta-analysis of magnetic resonance imaging studies. Hum. Brain Mapp. 2009 30 : 3719 3735.
104. Frodl T, Schüle C, Schmitt G et al. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch. Gen. Psychiatry 2007 64 : 410 416.
105. Frodl T, Möller HJ, Meisenzahl E. Neuroimaging genetics: New perspectives in research on major depression. Acta Psychiatr. Scand. 2008 118 : 363 372.
106. Shimizu E, Hashimoto K, Iyo M. Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: The possibility to explain ethnic mental traits. Am. J. Med. Genet. 2004 126B : 122 123.
107. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorders: Evidence from a family-based association study. Am. J. Hum. Genet. 2002 71 : 651 655.
108. Sklar P, Gabriel SB, Mclnnis MG et al. Family-based association study of 76 candidate genes in bipolar disorders: BDNF is a potential risk locus. Mol. Psychiatry 2002 7 : 579 593.
109. Vincze I, Perroud N, Buresi C et al. Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene. Bipolar Disord. 2008 10 : 580 587.
110. Nakata K, Ujike H, Sakai A et al. Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci. Lett. 2003 337 : 17 20.
111. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatry 2000 48 : 766 777.
112. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 2001 50 : 260 265.
113. Dunham JS, Deakin JF, Miyajima F, Payton A, Toro CT. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. J. Psychiatr. Res. 2009 43 : 1175 1184.
114. Mann JJ, Apter A, Bertolote J et al. Suicide prevention strategies: A systemic review. JAMA 2005 294 : 2064 2074.
115. Novick DM, Swartz HA, Frank E. Suicide attempts in bipolar I and bipolar II disorder: A review and meta-analysis of the evidence. Bipolar Disord. 2010 12 : 1 9.
116. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch. Gen. Psychiatry 2003 60 : 804 815.
117. Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res. Mol. Brain Res. 2005 136 : 29 37.
118. Pandey GN, Ren X, Rizavi HS, Conley RR, Roberts RC, Dwivedi Y. Brain-derived neurotrophic factor and tyrosine kinase B receptor signaling in post-mortem brain of teenage suicide victims. Int J Neuropsychopharmacol. 2008 11 : 1047 1061.
119. Ernst C, Deleva V, Deng X et al. Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Arch. Gen. Psychiatry 2009 66 : 22 32.
120. Keller S, Sarchiapone M, Zaeeilli F et al. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch. Gen. Psychiatry 2010 67 : 258 267.
121. Radka SF, Holst PA, Fritsche M, Atlar CA. Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res. 1996 709 : 122 130.
122. Yamamoto H, Gurney ME. Human platelets contain brain-derived neurotrophic factor. J. Neurosci. 1990 10 : 3469 3478.
123. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998 37 : 1553 1561.
124. Karege F, Schwald M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain platelets. Neurosci. Lett. 2002 328 : 261 264.
125. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002 109 : 143 148.
126. Shimizu E, Hashimoto K, Okamura N et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients without or with antidepressants. Biol. Psychiatry 2003 54 : 70 75. (Pubitemid 36776725)
127. Piccinni A, Marazziti D, Catena M et al. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J. Affect. Disord. 2008 105 : 279 283.
128. Gervasoni N, Aubry JM, Bondolfi G et al. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 2005 51 : 234 238.
129. Aydemir O, Yalcin ES, Aksaray S et al. Serum brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006 30 : 1256 1230.
130. Yoshimura R, Mitoma M, Sugita A et al. Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007 31 : 1034 1037.
131. Karege F, Bondolfi G, Gervasoni N et al. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol. Psychiatry 2005 57 : 1068 1072.
132. Aydemir O, Deveci A, Taskin OE, Taneli F, Esen-Danaci A. Serum brain-derived neurotrophic factor level in dysthymia: A comparative study with major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007 31 : 1023 1026. (Pubitemid 46810091)
133. Huang TL, Lee CT, Liu YL. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants. J. Psychiatric. Res. 2007 45 : 521 525.
134. Gonul AS, Akedeniz F, Taneli F et al. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur. Arch. Psychiatry Clin. Neurosci. 2005 255 : 381 386.
135. Monteleone P, Serritella C, Martiadis V, Maj M. Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders. Bipolar Disord. 2008 10 : 95 100.
136. Hashimoto K. BDNF and major depression. Brain Sci. Ment. Disord. 2009 20 : 55 60 (in Japanese).
137. Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications. Biol. Psychiatry 2008 64 : 527 532.
138. Brunoni AR, Lopes M, Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: Implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 2008 11 : 1169 1180.
139. Shi Y, You J, Yuan Y, Zhang X. Plasma BDNF and tPA are associated with late-onset geriatric depression. Psychiatry Clin. Neurosci. 2010 64 : 239 248.
140. Bocchio-Chiavetto L, Zanardini R, Bortolomasi M et al. Electroconvulsive therapy (ECT) increases serum brain-derived neurotrophic factor (BDNF) in drug resistant depressed patients. Eur. Neuropsychopharmacol. 2006 16 : 620 624. (Pubitemid 44781079)
141. Marano CM, Phatak P, Vemylapalli UR et al. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: A pilot study in patients with major depression. J. Clin. Psychiatry 2007 68 : 512 517.
142. Okamoto T, Yoshimura R, Ikenouchi-Sugita A et al. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: A pilot study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008 32 : 1185 1190.
143. Hu Y, Yu X, Yang F et al. The level of serum brain-derived neurotrophic factor is associated with the therapeutic efficacy of modified electroconvulsive therapy in Chinese patients with depression. J. ECT 2010 26 : 121 125.
144. Fernandes B, Gama CS, Massuda R et al. Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): A pilot study in drug resistant depressed patients. Neurosci. Lett. 2009 453 : 195 198.
145. Grønli O, Stensland GØ, Wynn R, Olstad R. Neurotrophic factors in serum following ECT: A pilot study. World J. Biol. Psychiatry 2009 10 : 295 301.
146. Lang UE, Hellweg R, Gallinat J, Bajbouj M. Acute prefrontal cortex transcranial magnetic stimulation in healthy volunteers: No effects on brain-derived neurotrophic factor (BDNF) concentrations in serum. J. Affect. Disord. 2008 107 : 255 258.
147. Cunha AB, Frey BN, Andreazza AC et al. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci. Lett. 2006 398 : 215 219.
148. Palomino A, Vallejo-Illarramendi A, González-Pinto A et al. Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients. Schizophr. Res. 2006 86 : 321 322.
149. Machado-Vieira R, Dietrich MO, Leke R et al. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol. Psychiatry 2007 61 : 142 144.
150. de Oliveira GS, Ceresér KM, Fernandes BS et al. Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J. Psychiatr. Res. 2009 43 : 1171 1174.
151. Yoshimura R, Nakano Y, Hori A et al. Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders. Hum. Psychopharmacol. 2006 21 : 433 438.
152. Mackin P, Gallagher P, Watson S, Young AH, Ferrier IN. Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia. Aust. N. Z. J. Psychiatry 2007 41 : 321 326.
153. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int. J. Neuropsychopharmacol. 2009 12 : 447 458.
154. Dias VV, Brissos S, Frey BN et al. Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder. Bipolar Disord. 2009 11 : 663 671.
155. Lin PY. State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder: A meta-analytic study. Neurosci. Lett. 2009 466 : 139 143.
156. Woodside BD, Staab R. Management of psychiatric comorbidity in anorexia nervosa and bulimia nervosa. CNS Drugs 2006 20 : 655 663.
157. Weissman MM, Wickramaratne P, Adams PB et al. The relationship between panic disorder and major depression. A new family study. Arch. Gen. Psychiatry 1993 50 : 767 780.
158. Buckley PF, Miller BJ, Lehrer DS, Castle DJ. Psychiatric comorbidities and schizophrenia. Schizophr. Bull. 2009 35 : 383 402.
159. Nakazato M, Hashimoto K, Shimizu E et al. Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders. Biol. Psychiatry 2003 54 : 485 490. (Pubitemid 37289455)
160. Monteleone P, Fabrazzo M, Martiadis V, Serritella C, Pannuto M, Maj M. Circulating brain-derived neurotrophic factor is decreased in women with anorexia and bulimia nervosa but not in women with binge-eating disorder: Relationships to co-morbid depression, psychopathology and hormonal variables. Psychol. Med. 2005 35 : 897 905.
161. Saito S, Watanabe K, Hashimoto K, Saito T. Low serum BDNF and food intake regulation: A possible new explanation of the pathophysiology of eating disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009 33 : 312 316.
162. Hashimoto K, Koizumi H, Nakazato M, Shimizu E, Iyo M. Role of brain-derived neurotrophic factor in eating disorders: Recent findings and its pathophysiological implications. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005 29 : 499 504.
163. Kobayashi K, Shimizu E, Hashimoto K et al. Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: As a biological predictor of response to group cognitive behavioral therapy. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005 29 : 658 663.
164. Ströhle A, Stoy M, Graetz B et al. Acute exercise ameliorates reduced brain-derived neurotrophic factor in patients with panic disorder. Psychoneuroendocrinology 2010 35 : 364 368.
165. Deveci A, Aydemir O, Taskin O, Taneli F, Esen-Danaci A. Serum brain-derived neurotrophic factor levels in conversion disorder: Comparative study with depression. Psychiatry Clin. Neurosci. 2007 61 : 571 573. (Pubitemid 47414862)
166. Ikeda Y, Yahata N, Ito I et al. Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia. Schizophrenia Res. 2008 101 : 58 66.
167. Shimizu E, Hashimoto K, Watanabe H et al. Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from control. Neurosci. Lett. 2003 351 : 111 114.
168. Carlino D, Leone E, Tongiorgi E, De Vanna M. Decreased serum to proBDNF/BDNF ratio in patients with schizophrenia. Eur. Neuropsychopharmacol. 2008 18 (Suppl. 4 S395.
169. Mandel AL, Ozdener H, Utermohlen V. Identification of pro- and mature brain-derived neurotrophic factor in human saliva. Arch. Oral Biol. 2009 54 : 689 695.
170. Cattaneo A, Bocchio-Chiavetto L, Zanardini R et al. BDNF Val66Met polymorphism and protein levels in amniotic fluid. BMC Neurosci. 2010 11 : 16.
171. Carvalho AL, Caldeira MV, Santos SD, Duarte CB. Role of the brain-derived neurotrophic factor at glutamatergic synapses. Br. J. Pharmacol. 2008 153 (Suppl. 1 S310 S324.
172. Mattson MP. Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann. N. Y. Acad. Sci. 2008 1144 : 97 112.
173. Pittenger C, Sanacora G, Krystal JH. The NMDA receptor as a therapeutic target in major depressive disorder. CNS Neurol. Disord. Drug Targets 2007 6 : 101 115.
174. Hashimoto K, Sawa A, Iyo M. Increased levels of glutamate in brains from patients with mood disorders. Biol. Psychiatry 2007 62 : 1310 1316.
175. Sanacora G, Zarate CA, Krystal JH, Manji HK. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat. Rev. Drug Discov. 2008 7 : 426 437.
176. Skolnick P, Popik P, Trullas R. Glutamate-based antidepressants: 20 years on. Trends Pharmacol. Sci. 2009 30 : 563 569.